Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma (Q47551890)
Jump to navigation
Jump to search
scientific article published on 10 September 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma |
scientific article published on 10 September 2017 |
Statements
1 reference
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma (English)
1 reference
Paolo A Ascierto
Mario Mandala
Michele Del Vecchio
Helen J Gogas
C Lance Cowey
Michael Schenker
Jean-Jacques Grob
Marcus O Butler
Mark R Middleton
Michele Maio
Victoria Atkinson
Paola Queirolo
Rene Gonzalez
Ragini R Kudchadkar
Michael Smylie
Michael B Atkins
Shailender Bhatia
Celeste Lebbé
Kenji Yokota
Naoya Yamazaki
Tae M Kim
Veerle de Pril
Javier Sabater
Anila Qureshi
CheckMate 238 Collaborators
10 September 2017
1 reference